Olr222 inhibitors represent a specific class of chemical compounds that interact with and modulate the activity of the Olr222 receptor, a G-protein-coupled receptor (GPCR) found in certain biological systems. These inhibitors are structurally diverse, with each compound potentially offering different affinities, selectivity, and mechanisms of inhibition. The Olr222 receptor is part of a larger family of olfactory receptors that are typically involved in detecting and responding to odorant molecules. However, like other GPCRs, the Olr222 receptor may have additional roles that extend beyond olfaction, participating in various signaling pathways within cells. Inhibitors of the Olr222 receptor work by binding to the active site or allosteric sites of the receptor, thereby preventing the receptor from interacting with its natural ligands or blocking subsequent signal transduction cascades.
The chemical architecture of Olr222 inhibitors often includes functional groups that allow them to specifically target and bind to the Olr222 receptor. This binding can result in conformational changes in the receptor, which can alter its activity or hinder its normal interactions with other cellular components. Research into the structure-activity relationships (SAR) of Olr222 inhibitors focuses on understanding how changes in the molecular structure of these compounds affect their ability to inhibit receptor activity. Such studies might involve various techniques, such as molecular docking, site-directed mutagenesis, and computational modeling, to predict and optimize the inhibitory potential of these compounds. Overall, the study of Olr222 inhibitors contributes significantly to the broader understanding of GPCR modulation, offering insights into the diverse roles these receptors play in cellular signaling processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
A calcium channel blocker, amlodipine affects vascular smooth muscle and cardiac function, potentially impacting Olr222. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
A statin class drug, atorvastatin influences cholesterol metabolism, which may indirectly modulate Olr222. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
An ACE inhibitor, captopril affects the renin-angiotensin system, potentially influencing Olr222 indirectly. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
A cardiac glycoside, 12β-Hydroxydigitoxin impacts heart function, which could indirectly influence Olr222 activity. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
An angiotensin receptor blocker, losartan impacts blood pressure regulation, potentially affecting Olr222. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
A statin that modulates cholesterol synthesis, potentially influencing Olr222 through lipid metabolism pathways. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
A proton pump inhibitor, omeprazole affects gastric acid secretion, potentially impacting Olr222 indirectly. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
An antidiabetic drug, pioglitazone affects insulin sensitivity, which could impact Olr222. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Another statin, rosuvastatin alters lipid metabolism, potentially affecting Olr222 indirectly. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $40.00 $92.00 $122.00 | 4 | |
An angiotensin II receptor antagonist, valsartan affects blood pressure, potentially influencing Olr222. | ||||||